Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06724159
What this trial is testing

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.

Who this might be right for
Genitourinary Cancers
Spanish Oncology Genito-Urinary Group 500
Not applicableEnded earlyNCT04436120
What this trial is testing

Treatment Resistance Following Anti-cancer Therapies

Who this might be right for
Disease Progression
Pfizer 38
Not applicableStudy completedNCT02981797
What this trial is testing

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

Who this might be right for
Prostate CancerProstate Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute 10
Not applicableLooking for participantsNCT07219303
What this trial is testing

Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Fox Chase Cancer Center 80
Early research (Phase 1)Study completedNCT04148937
What this trial is testing

The CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 52
Testing effectiveness (Phase 2)Study completedNCT03069937
What this trial is testing

Phase II Study of Docetaxel Before Degarelix in Patients With Newly Diagnosed Metastatic Prostate Cancer.

Who this might be right for
Metastatic Prostatic Adenocarcinoma
Medical University of South Carolina 52
Testing effectiveness (Phase 2)Study completedNCT01505868
What this trial is testing

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaLymphadenopathy+4 more
M.D. Anderson Cancer Center 170
Not applicableLooking for participantsNCT06101290
What this trial is testing

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

Who this might be right for
Prostate CancerOligoprogressiveUrothelial Carcinoma+1 more
University of California, Davis 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT03525262
What this trial is testing

Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)

Who this might be right for
Prostate Cancer Adenocarcinoma
University of Texas Southwestern Medical Center 124
Not applicableLooking for participantsNCT04610372
What this trial is testing

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)

Who this might be right for
Oligometastatic Prostate Cancer
British Columbia Cancer Agency 168
Not applicableStudy completedNCT03503643
What this trial is testing

Hemi-Gland Cryoablation for Prostate Cancer at UCLA

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Disease
Jonsson Comprehensive Cancer Center 354
Testing effectiveness (Phase 2)Study completedNCT03113617
What this trial is testing

68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate AdenocarcinomaStage IV Prostate Adenocarcinoma
Andrei Iagaru 44
Not applicableStudy completedNCT00877682
What this trial is testing

Prostate Conformal Cryotherapy

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT00446836
What this trial is testing

Efficacy and Safety Study of Xyotax to Treat Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 29
Not applicableUnknownNCT00392535
What this trial is testing

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 3,216
Large-scale testing (Phase 3)Study completedNCT00127478
What this trial is testing

A Long Term Safety Study With Atrasentan

Who this might be right for
Prostate CancerAdenocarcinoma
Abbott 166
Large-scale testing (Phase 3)Looking for participantsNCT06931340
What this trial is testing

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Alliance for Clinical Trials in Oncology 1,260
Testing effectiveness (Phase 2)WithdrawnNCT04331717
What this trial is testing

Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaObesity, Morbid
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT01468532
What this trial is testing

Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Barbara Ann Karmanos Cancer Institute 18
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Next Page